Dr. Patricia Martin has a solid background in molecular microbiology in the context of the pathophysiology of infectious diseases.
After a thesis on the genomic instability of an antibiotic-producing bacterium, she turned to study the pathogenicity of bacteria, such as meningococcus in Oxford then in Paris and Escherichia coli in Toulouse. During this academic career she acquired skills in project management, team management and communication.
In 2020 she joined Vibiosphen as Chief Scientific Officer.
Patricia Martin is the author of 34 international publications, 2 patents and is authorized to supervise research.